26 Share-based payments During the year to 31 March 2010, various equity-settled share-based payment arrangements existed, which are described below: Sharesave scheme Deferred Performance Executive share bonus Duration Type of arrangement share plan option scheme share plan in years Timing of grant Bi-annually Annually in June Annually in July Annually in June Annually in in June and note a December November Number of options shares granted in year to 31 March 2010 5 001 896 3 85 632 5 45 453 Number of options shares granted in year to 31 March 2009 2 478 568 19 026 3 66 029 148 132 5 31 340 61 893 Fair value per share for 2010 grant pence 234 3 90 5 97 Fair value per share for 2009 grant pence 170 215 3 66 67 5 75 76 Valuation basis Monte Carlo Binomial Lattice Monte Carlo Black-Scholes Black-Scholes Contractual life 10 years 10 years 3 years 3 5 years 3 5 years Vesting conditions note b note c note d note e note e a The last grant under this scheme was made in June 2004. b F or the year ended 31 March 2010, exercise of 419,403 shares is not subject to any performance conditions, exercise of 269,616 shares is dependent on total shareholder return and the exercise of 4,312,877 shares is dependent 50% on total shareholder return and 50% on earnings per share.
For the year ended 31 March 2009, exercise was dependent on total shareholder return by reference to a competitor group over a three-year period following grant.
c Exercise is dependent on earnings per share performance relative to inflation over a three-year period following grant.
Participants are not entitled to dividends prior to the exercise of options.
d E xecutives have previously had the opportunity to defer up to 50% of their annual cash bonus after deduction of tax, national insurance or other social security payments and invest the amount deferred in the Companys shares.
Subject to the satisfaction of employment conditions and a performance target over the performance period as described in b above, participants received awards of matching shares based on the number of shares which could have been acquired from the gross bonus amount deferred by the participant.
During the performance period, dividends were paid on the deferred shares but not on matching shares.
This plan was suspended during the year ended 31 March 2009. e Options granted in the years to 31 March 2009 and 31 March 2010 were by invitation at a 10% discount to the market price.
Options are exercisable at the end of a three-year or five-year savings contract.
The Group recognised total expenses before tax of 5 million 2009 5 million related to equity-settled share-based payment transactions during the year.
Details of the movements for equity-settled share option schemes during the year to 31 March were as follows: 31 March 2010 31 March 2009 Weighted Weighted average average exercise exercise Shares price Shares price number pence number pence Outstanding at 1 April 9 783 526 111 11 664 517 117 Granted 5 132 981 11 2 804 988 42 Exercised 1 064 000 174 1 732 598 149 Lapsed 2 552 549 38 2 953 381 48 Outstanding at 31 March 11 299 958 76 9 783 526 111 Tate & Lyle Annual Report 2010 93 Shareholder information Financial statements Governance Business review Overview Notes to the consolidated financial statements 26 Share-based payments continued The weighted average Tate & Lyle PLC share price at the date of exercise for share options exercised during the year was 377 pence 2009 467pence.
At 31 March 2010, 1,891,485 2009 3,017,439 of the outstanding options were exercisable at a weighted average exercise price of 329 pence 2009 280 pence.
A detailed breakdown of the range of exercise prices for options outstanding at 31 March is shown in the table below: Year to 31 March 2010 Year to 31 March 2009 Weighted Weighted Weighted Weighted average average average average Number remaining exercise Number remaining exercise outstanding contractual price outstanding contractual price at end of year life in months pence at end of year life in months pence At nil cost 8 846 512 55.6 6 649 565 52.9 0.01 to 1.99 2.00 to 3.99 2 207 816 41.6 340 2 910 196 53.5 338 4.00 to 7.99 245 630 36.5 443 223 765 23.2 466 Total 11 299 958 52.5 76 9 783 526 52.3 93 The fair value of grants is measured using the valuation technique that is considered to be the most appropriate to value each class of grant.
These include Binomial Lattice models, Black-Scholes calculations and Monte Carlo simulations.
These valuations take into account factors such as non-transferability, exercise restrictions and behavioural considerations.
Key assumptions are detailed below: Sharesave Performance scheme At 31 March 2010 share plan December Expected volatility 40% 35% Expected life n a 3.3 5.3 years Risk-free rate 3% 3.4% Expected dividend yield 5.15%-7.8% 5.7% Forfeiture rate 0% 10% Correlation with comparators 35% n a Volatility of comparators 26%-144% n a Expectations of meeting performance criteria 100% n a Weighted average market price at date of grant pence 346 418 Sharesave Sharesave Deferred Performance scheme scheme At 31 March 2009 bonus plan share plan June December Expected volatility 30% 30% 30% 30% Expected life n a n a 3.5 5.5 years 3.5 5.5 years Risk-free rate 5.3% 4.5% 4.6% Expected dividend yield 5.6% 5.7% 5.7% 4.9% Forfeiture rate 0% 0% 10% 10% Correlation with comparators 30% 30% n a n a Volatility of comparators 17-56% 17-53% n a n a Expectations of meeting performance criteria 100% 100% n a n a Weighted average market price at date of grant pence 401 392 398 400 The expected volatility is based on the Companys historical volatility over the three-year period prior to each award date.
